Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: Availability of randomized controlled trial (RCT) protocols is essential for the interpretation of trial results and research transparency. STUDY DESIGN AND SETTING: In this study, we determined the availability of RCT protocols approved in Switzerland, Canada, Germany and the UK in 2012. For these RCTs, we searched PubMed, Google Scholar, Scopus, and trial registries for publicly available protocols and corresponding full-text publications of results. We determined the proportion of RCTs with: (1) publicly available protocols, (2) publications citing the protocol, and (3) registries providing a link to the protocol. A multivariable logistic regression model explored factors associated with protocol availability. RESULTS: 326 RCTs were included of which 118 (36.2 %) made their protocol publicly available; 56 (47.6% 56/118) as a peer-reviewed publications and 48 (40.7%, 48/118) provided as supplementary material. 90.9% (100/110) of the protocols were cited in the main publication and 55.9% (66/118) were linked in clinical trial registry. Larger sample size (>500; OR 5.90, 95% CI, 2.75-13.31) and investigator-sponsorship (OR 1.99, 95% CI, 1.11-3.59) were associated with increased protocol availability. Most protocols were made available shortly before the publication of the main results. CONCLUSION: RCT protocols should be made available at an early stage of the trial.

Original publication

DOI

10.1016/j.jclinepi.2022.05.014

Type

Journal article

Journal

J clin epidemiol

Publication Date

30/05/2022

Keywords

Randomized controlled trials, meta-research, protocol publication, transparency, trial protocols, trial registration